错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Selection of outcome measurement instruments for a core outcome set for trials aimed at improving appropriate polypharmacy in older people in primary care: a Delphi consensus study

  • Mubarak N. Alqahtani,
  • Heather E. Barry,
  • Carmel M. Hughes

摘要

Background

Despite developing a polypharmacy core outcome set (COS) in primary care, it is not clear how these outcomes should be measured.

Aim

To select outcome measurement instruments (OMIs) for a COS targeting appropriate polypharmacy in older patients in primary care.

Method

Following the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) guideline, OMIs were identified from a Cochrane review focusing on appropriate polypharmacy. The quality of OMIs was assessed using a published checklist. Subsequently, two rounds of Delphi questionnaires were conducted via the SoGoSurvey® platform, engaging stakeholders (researchers, clinicians and journal editors specialising in geriatric primary care) to achieve consensus on OMIs using a scale encompassing “agree”, “disagree”, or “unsure”. Consensus was achieved if 70% or more participants chose “agree” and 15% or fewer chose “disagree.”

Results

The quality of 20 OMIs identified from the Cochrane review was evaluated. Seven OMIs were selected based on meeting the COSMIN guideline’s minimum requirements. Out of 188 potential participants, 57 (30.3%) consented to participate. Rounds 1 and 2 of Delphi exercises were completed by 50 respondents, achieving agreement on three OMIs: ‘number of serious adverse drug reactions (ADRs)’ (98%), ‘number of deaths’ (76%), and ‘number of patients who fell’ (70%) for measuring ‘serious ADRs,’ ‘mortality,’ and ‘falls,’ respectively. No agreement was reached for ‘medication appropriateness,’ ‘medication side-effects,’ ‘quality of life,’ and ‘medication regimen complexity.’

Conclusion

OMIs were selected for a limited number of outcomes in the polypharmacy COS. Future research should identify suitable OMIs for the remaining four outcomes.